Last reviewed · How we verify
⁶⁸Ga-FC516
⁶⁸Ga-FC516 is a Small molecule drug developed by FindCure Biosciences (ZhongShan) Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | ⁶⁸Ga-FC516 |
|---|---|
| Sponsor | FindCure Biosciences (ZhongShan) Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ⁶⁸Ga-FC516 CI brief — competitive landscape report
- ⁶⁸Ga-FC516 updates RSS · CI watch RSS
- FindCure Biosciences (ZhongShan) Co., Ltd. portfolio CI
Frequently asked questions about ⁶⁸Ga-FC516
What is ⁶⁸Ga-FC516?
⁶⁸Ga-FC516 is a Small molecule drug developed by FindCure Biosciences (ZhongShan) Co., Ltd..
Who makes ⁶⁸Ga-FC516?
⁶⁸Ga-FC516 is developed by FindCure Biosciences (ZhongShan) Co., Ltd. (see full FindCure Biosciences (ZhongShan) Co., Ltd. pipeline at /company/findcure-biosciences-zhongshan-co-ltd).
What development phase is ⁶⁸Ga-FC516 in?
⁶⁸Ga-FC516 is in Phase 1.
Related
- Manufacturer: FindCure Biosciences (ZhongShan) Co., Ltd. — full pipeline
- Compare: ⁶⁸Ga-FC516 vs similar drugs
- Pricing: ⁶⁸Ga-FC516 cost, discount & access